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ABSTRACT
N6-methyladenosine (m6A) is the most abundant
base modification found in messenger RNAs (mR-
NAs). The discovery of FTO as the first m6A mRNA
demethylase established the concept of reversible
RNA modification. Here, we present a comprehen-
sive transcriptome-wide analysis of RNA demethyla-
tion and uncover FTO as a potent regulator of nu-
clear mRNA processing events such as alternative
splicing and 3’ end mRNA processing. We show that
FTO binds preferentially to pre-mRNAs in intronic re-
gions, in the proximity of alternatively spliced (AS)
exons and poly(A) sites. FTO knockout (KO) results
in substantial changes in pre-mRNA splicing with
prevalence of exon skipping events. The alterna-
tive splicing effects of FTO KO anti-correlate with
METTL3 knockdown suggesting the involvement of
m6A. Besides, deletion of intronic region that con-
tains m6A-linked DRACH motifs partially rescues the
FTO KO phenotype in a reporter system. All together,
we demonstrate that the splicing effects of FTO are
dependent on the catalytic activity in vivo and are me-
diated by m6A. Our results reveal for the first time the
dynamic connection between FTO RNA binding and
demethylation activity that influences several mRNA
processing events.
INTRODUCTION
Reversible N6-methyladenosine (m6A) is the most preva-
lent modification in eukaryotic mRNA (1–8). It was ini-
tially discovered together with the 7-methylguanosine cap
already in the 1970s (9–16), although the precise locations
of m6A within mRNAs were uncovered by transcriptome-
wide studies only in 2012 (1,2). The most striking feature
that emerged from these studies was the widespread pres-
ence of m6A in more than half of all mammalian mRNAs
and few hundred non-coding RNAs (ncRNAs) (1,2,17).
The RNA modification by m6A affects multiple aspects of
mRNA metabolism, such as alternative splicing (AS) (18–
21), stability (3–5,8,22), translation efficiency (23–26) or lo-
calization (27).
The dynamics of m6A is coordinated by an interplay
between the m6A writers, erasers and readers that de-
posit, remove or specifically bind m6As, respectively. The
mRNA m6A writer is represented by a multi-subunit
methyltransferase complex consisting of the core MMW
complex that is formed by the methyltransferase-like 3
and 14 (METTL3 and METTL14), Wilms’ tumor 1-
associating protein (WTAP) and the protein Virilizer ho-
molog (KIAA1429) (5–7).METTL3 possessesmethyltrans-
ferase activity, whereas the METTL14 is catalytically inac-
tive and serves as an RNA binding platform for METTL3,
enhancing its activity (7,28,29). WTAP and KIAA1429
are auxiliary proteins, which promote RNA methylation in
vivo, although the exact mechanism is still unknown (5–
7). Most of the m6A marks are found within the consen-
sus motif DRACH (D = A, G or U; R = A or G; H =
A, U or C) (7,30). Whereas DRACH occurs rather fre-
quently in mRNA, only a fraction of the sites are methy-
lated in vivo. Notably, m6A methylation is non-randomly
distributed throughout the mRNA body being enriched
particularly around the transcription start site (TSS) and
the stop codon/beginning of the last exon (1,2). However,
the cause of the enrichment in such specific sites in mR-
NAs is currently unknown. Them6A is interpreted bym6A-
binding proteins - readers. Direct m6A readers possess the
RNA-binding YTH domain, which is responsible for m6A
recognition (2,4,6) and mediates divergent roles of m6A in
the RNA metabolism (4,18,25). The best characterized is
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the role of YTHDF2, which negatively regulates stability of
m6A modified mRNA (4). This function of m6A has a par-
ticularly important role in the regulation of pluripotency in
embryonic stem cells (3,8).
The presence of m6A can change structural properties of
the adjacent RNA region and influence binding of RNA-
binding factors (20). To date, this feature appears to play
a role in the regulation of alternative splicing (20). Other
studies linked m6A to a transcription factor activity (31)
or regulation of alternative polyadenylation (poly(A)) site
usage (32) underscoring the role of m6A in coupling tran-
scription with pre-mRNA processing. However underlying
molecular mechanisms are not well understood (32).
Adenosine methylation can be directly reversed by so
called erasers, represented inmammals by at least twom6A-
specific demethylases––ALKBH5 (AlkB homolog 5) and
FTO (fatmass and obesity-associated) (27,33). They belong
to a broader family of AlkB dioxygenases. ALKBH5 local-
izes to the nucleus and its depletion leads to global reduc-
tion of poly(A) RNAs in this cellular compartment, sug-
gesting a role in the regulation of nucleo-cytoplasmic shut-
tling of mRNA (34). FTO is localized in the nucleus and
cytoplasm (33,35) and it was linked tomultiple processes in-
cluding splicing, sensing of amino acids and differentiation
of preadipocytes (19,36,37). Interestingly, neitherALKBH5
nor FTO display a preference for DRACH m6A motif in
vitro (38). Currently, the target repertoire of ALKBH5 and
FTO remains largely unknown and it is unclear to what ex-
tent they are redundant in function. The expression pattern
in mammalian tissues indicates that they have distinct roles
in animal physiology. ALKBH5 is highly expressed in testis
and is crucial during spermatogenesis (27), whereas FTO is
widely expressed in all adult and fetal tissues with the high-
est expression in the brain (39). Although FTO mutations
were initially associated with obesity (39), this role is cur-
rently under debate (40,41).Despite the recent enormous in-
terest in m6A RNA modifications the demethylases remain
the least-characterized parts of this pathway.
Here, we use a combination of CLIP-seq andRNA-seq to
show that FTO is a potent regulator ofmultiplemRNApro-
cessing events. We uncover a novel role of FTO in alterna-
tive splicing and demonstrate that FTO binding to regions
proximal to alternative exons triggers their inclusion into
mRNA. In addition, FTO depletion results in upregulation
of terminal mRNA exons. This links FTO to the previously
suggested role of m6A in regulation of alternative poly(A)
site usage and 3′ end mRNA processing (32). Taken to-
gether, our results reveal the direct role of the FTOdemethy-
lase in regulation of several nuclear pre-mRNA processing
events.
MATERIALS AND METHODS
Cell culture and manipulation
HumanHEK293 Flp-In T-REx cell line (293T) (Invitrogen)
cells were cultured in Dulbecco’s Modified Eagle Medium
(DMEM) supplementedwith 10% fetal bovine serum (FBS)
at 37◦C in the presence of 5% CO2. Transfections of plas-
mids were performed using TURBOFECT reagent (Fer-
mentas) at 70% confluency according to manufacturer’s in-
structions.
Knockout of FTO
Both alleles of FTO gene were knocked out using the
nickase CRISPR–Cas9 system (42,43) according to (44).
Shortly, oligonucleotide sequences targeting both strands of
exon 2 of FTO were cloned into pX461 vector (Addgene #
48140) and cotransfected into the 293T cell line. Cells were
checked for GFP expression after 24 h, counted and seeded
with the density 0.5 cell/well in 96-well plates. Expression of
FTO was analyzed in five weeks by western blot with rabbit
polyclonal antibodies against FTO (Abcam, EPR6894).
Site-directed mutagenesis
H231A, D233A double mutant of FTO was generated by
site directed mutagenesis. Shortly, full length FTO sub-
cloned in pcDNA5/FRT/TOwas subjected to inverse PCR
with oligonucleotide primers containing desired mutations
(FTO HDmut fw and FTO HDmut rev). The PCR reac-
tionwas then digestedwithDpnI (NEB) to remove template
DNA and transformed into Escherichi coli strain TOP10.
Colonies were screened for the mutation and successful
clones were confirmed by sequencing.
Cloning and stable cell lines preparation
The full length FTO gene (AA 1–505) was amplified from
the cDNA library prepared from 293T cells. PCR prod-
uct was digested with NotI and XhoI and ligated into
pcDNA5/FRT/TO plasmid (Invitrogen) containing an N-
terminal FLAG tag. Successful clones were verified by se-
quencing.
The 293T cells were grown to 70% confluency and co-
transfected with 0.6g of pcDNA5/FRT/TO-3xN-FLAG-
FTO and 6 g of pOG44 (Invitrogen). After 24 h, cells
were transferred to 150 mm dish and stable recombinants
were selected using 100 g/ml of hygromycin B. Cells
were cultivated until individual colonies were visible on the
plate. Several colonies were tested for Zeocin sensitivity and
doxycycline-inducible expression of FLAG-tagged protein
by western blot.
Immunofluorescence
Cells were grown on polyethyleneimine coated cover-
slips, washed with pre-warmed PBS and fixed in 3.7%
paraformaldehyde. Fixed cells were washed with PBS, per-
meabilized by 0.2% TritonX-100 in PBS for 20 min and
blocked in 5% horse serum in PBS. After 1 h blocking at
RT, cells were incubated with anti-FTO primary antibody
(Abcam, 1:250) in 3% horse serum for 1 h at RT. Cells were
washed three times for 10min with PBS, incubated withmix
of Alexa488 secondary antibodies (Invitrogen, 1:800) and
DAPI (Sigma, 1:500) in PBS for 30 min at RT in the dark.
Cells were washed with PBST and PBS and finally sterile
ddH2O and fixed on slides in Mowiol 4-88 (Sigma) with
DABCO. Samples were imaged by Olympus FluoView-500
confocal imaging system combined with an inverted Olym-
pus IX-81 microscope. The images were recorded using an
Olympus DP70 CCD camera. All pictures were taken at
600-foldmagnification. Pictures consist of 10 overlapped in-
dividual sections, which are 0.4 m apart from each other.
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All pictures were processed by software FluoView (Olym-
pus).
CLIP-seq protocol
CLIP-seq was performed with modifications according to
(45,46). Briefly, RNAse I was used for RNA fragmentation,
pre-adenylated 3′ linker and truncated RNA ligase 2 (NEB)
was used for on-beads 3′ linker ligation and cDNA library
was amplified by 25 PCR cycles (Detailed CLIP-seq proce-
dure can be found in supplementary methods).
RNA immunoprecipitation
Cells expressing FLAG-tagged FTO were grown to 90%
confluence, washed with ice cold PBS and lysed in lysis
buffer (LB) containing 150 mM NaCl, 50 mM Tris pH
7.6, 1% Triton X-100, EDTA-free Complete Protease In-
hibitor Cocktail (Roche), 1mMDTT,RNase In (Promega).
Lysates were sonicated 6 × 10 s at 7% amplitude, incubated
with Turbo DNase (Fermentas) for 15 min at 37◦C and
cleared by centrifugation. Supernatants were subsequently
pre-cleared with magnetic beads without antibodies for 1 h
at 4◦C. FLAGM2Magnetic beads (Sigma) were incubated
with 10 g of yeast tRNA for 1 h at 4◦C. The pre-cleared
extracts were applied on the pre-blocked FLAG beads and
incubated for 2 h at 4◦C. Beads were washed three times
withLB and the boundRNAwas extractedwith theTriPure
reagent (Roche) according to manufacturer’s instructions.
The isolated RNA was treated with the Turbo DNase (Fer-
mentas) and used as a template for cDNA synthesis by Su-
perscript III reverse transcriptase (Invitrogen) with random
hexamer priming. The cDNAwas subsequently analyzed by
semi-quantitative or real-time qPCR.
DNA library preparation for RNA-seq analysis
RNA-seq was performed on a 293T 3xN-FLAG-FTO over-
expressing cell line, FTO knockout cell line as well as the
293T cell line. RNA was isolated using TriPure Isolation
Reagent (Roche) and ribosomal RNAs were depleted with
RiboMinus Eukaryote System v2. Depletion of ribosomal
RNAwas checked onAgilent RNANanoChip. The cDNA
libraries were preparedwith ScriptSeq-v2RNA-seqLibrary
PreparationKit (Epicentre) according tomanufacturer’s in-
structions. Quality of libraries was assessed usingHigh Sen-
sitivityDNAAnalysis Kit (Agilent). DNA libraries were se-
quenced on Illumina HiSeq 2000, in the 2 × 125 bp paired-
end mode by the EMBL Genomics Core Facility, Heidel-
berg, Germany.
High-throughput sequencing data analysis
Raw reads were trimmed and quality control was performed
using TrimGalore! (Babraham Bioinformatics) with default
settings. Trimmed reads weremapped to the human genome
version hg19 using TopHat2 v 2.0.14 (47). CLIP-seq reads
weremapped both with and without the transcripts annota-
tion (Illumina iGenomes v. GRCh37). Both mappings were
combined and mapping positions were selected based on
minimal number of mismatches. CLIP-seq reads were cate-
gorized according to priority table (1. rRNA, 2. tRNA, 3.
snoRNA, 4. snRNA, 5. miRNA, 6. mRNA exon, 7. mRNA
intron, 8. mRNA unknown, 9. lincRNA, 10. repeat 11. an-
tisense mRNA, 12. unannotated).
To cluster the CLIP-seq reads we dissected the human
genome to 50 bp windows and calculated RPKM for all
windows in CLIP-seq and input (RNA-seq). Binding clus-
ters were filtered and selected based on two conditions.
First, we calculated enrichment of FTO CLIP RPKM in
cluster over input (RNAseq) and filtered only clusters,
which were enriched >2-fold. Second, to remove lowly cov-
ered regions, we selected only clusters with minimum of 10
reads coverage in all three replicates summed.
Differential gene and exon expression analysis was per-
formed using R packages DESeq2 (48) and DEXSeq re-
spectively according to documentation (49). Genes/exons
with an adjusted P-value < 0.05 were considered signif-
icantly DE. Top up/downregulated exons were selected
based on ordered adjusted P-values. Numbers of exons
were acquired by custom scripts from the Ensembl annota-
tion (GRCh37.75). MISO analysis was performed accord-
ing to documentation (50). The top 200 inclusion/exclusion
events were selected based on their respective Bayes fac-
tor. Splicing events with Bayes factor > 10 were considered
significant. Metagene analysis was performed with CGAT
tool bam2geneprofile.py (51) or custom scripts. GO analysis
was performed using R package GOSeq (52). RPKM cal-
culations in features were done using bedtools (53). CLIP-
seq/RNA-seq coverage plots were calculated using cover-
ageBed from the bedtools toolset and visualized using cus-
tom scripts inR.Genemodels were generated usingRpack-
age GenomeGraphs (54).
Alternative poly(A) (APA) site usage was estimated using
DaPars (55). APA events with adjusted P-value< 0.05 were
considered significant. Formotif analysis, binding sites were
selected based on the identification of crosslinking-induced
deletions in the CLIP reads. Positions with >5 reads cov-
erage and at least 5% of deletion frequency were selected.
K-mers were counted by ZOOPS (Zero or once per tran-
script) counting. Significance of motif enrichment was cal-
culated by Fisher’s exact test for each replicate separately,
and P-values were combined by Fisher’s method.
Reverse transcription and qPCR analysis
Total RNA isolated with TriPure reagent according to
the manufacturer’s instructions was treated with DNAse
(Turbo DNAse, Fermentas) and 2g of RNA was used for
reverse transcription (RT) with random hexamers and Su-
perScript III enzyme (ThermoFisher scientific). Typically
2 l of 2–10× diluted cDNA was used for PCR/qPCR
reaction. qPCR was performed using FastStart Universal
SYBR Green Master (Roche) on Roche LightCycler 480.
Each measurement was performed in three biological and
three technical replicates. Differential expression was cal-
culated using CT method. Data were normalized to ex-
pression of the housekeeping gene HPRT. Results are ex-
pressed as means and standard errors of the mean. P-values
were calculated using a two-tailed Student’s t-test.
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Splicing assay by using the minigene reporter construct
To generate the splicing minigene construct, the genomic
region chr5:137 495 750–137 494 549 (synthetic GeneArt
Strings purchased from Life Technologies) corresponding
to the AS exon 20/21 of the BRD8 gene (according to
reported isoforms NM 139199 and NM 006696, respec-
tively) and flanking intronic regions 462 bp upstream and
695 bp downstream was inserted into the pDESTsplice vec-
tor (pDESTsplice was a gift from Stefan Stamm, Addgene
plasmid #32484, (56)) using the Gibson Assembly Master
Mix (NewEngland BioLabs). The pDESRsplice-BRD8-del
construct lacks the 53 bp long intronic region downstream
of the AS exon, which was highly covered in the FTO-
CLIPseq results (it corresponds to the genomic position
chr5:137 495 164–137 495 112). In the pDESTsplice-BRD8-
mut construct, this 53 bp region was replaced by sequence
5′ GAGACGCCTAAGGTTAAGTCGCCCTCGCTCGC
TACTATGCGGTGTAGCTCTTC 3′, which is a sequence
not found in the human genome flanked by two restriction
sites.
The constructs were transiently expressed in 293T WT
and FTO KO cells, briefly, 1.5 g of the reporter construct
DNA was transfected to 80% confluent 293T cells in 6-well
culture plates using TURBOFECT following the manufac-
turer’s instructions (Fermentas). The cells were harvested
24 h after transfection and total RNA was isolated with
TriPure reagent according to the manufacturer’s instruc-
tions. The isolated RNA was treated with DNAse (Turbo
DNAse, Fermentas) and 2 g of RNA was used for reverse
transcription (RT) with random hexamers and SuperScript
III enzyme (ThermoFisher scientific). To assess the splic-
ing pattern, primers annealing to the rat insulin exons 2
and 3 were used (see the Supplementary Table 1 for the se-
quences). RT-PCR products were resolved on agarose gels
and signals were quantified by ImageJ (57).
RESULTS
Characterization of FTO RNA targets by CLIP-seq
To characterize the RNA targets bound by FTO, we per-
formed cross-linking and immunoprecipitation (CLIP-seq)
(46) of FTO in the human embryonic kidney HEK293 Flp-
In T-REx cell line (293T). To ensure high specificity of the
immunoprecipitation (IP), we prepared a stable 293T cell
line with inducible expression of FLAG-tagged full-length
FTO and optimized the immunoprecipitation (IP) condi-
tions and RNAse I fragmentation (Supplementary Figure
S1A and B).We performed three replicates of CLIP-seq fol-
lowed by high-throughput sequencing on the Illumina plat-
form, together with three replicates of RNA sequencing of
the same cell line (Input). The CLIP-seq libraries yielded 33
922 806, 40 223 089 and 96 201 502 reads, respectively. Af-
ter adapter trimming and collapsing of duplicate reads, we
were able to map more than 70% of the reads in all three
samples to the human genome version hg19 using tophat2
(47) (762 879, 1 633 537 and 4 669 684 uniquely mapped,
de-duplicated reads in three replicates). The distribution of
CLIP reads in RNA classes was reproducible and most of
the reads were mapped to mRNAs (42%), followed by ri-
bosomal RNAs (rRNAs) (26%), and small nuclear RNAs
(snRNAs) (4%) (Figure 1A, Supplementary Figure S1C).
To filter FTO binding sites and assess the reproducibil-
ity of the CLIP-seq datasets, we performed a read cluster-
ing analysis (see Methods for details). We used the filtering
condition >10 reads in a cluster and >2-fold enrichment
over input (RNAseq) in at least two replicates. This resulted
in a total number of 46 186 binding clusters in 9224 exons.
This is comparable to the number of peaks obtained in the
recent m6A miCLIP analysis, which revealed 27 771 m6A
peaks in 11,880 exons (17). We observed high correlation of
read counts in FTObinding clusters as well asmRNAexons
and mRNA introns (Supplementary Figure S1D). Unfil-
tered FTO-binding clusters with>20 reads revealed almost
>90% overlap of binding clusters in at least two biological
replicates (Supplementary Figure S1E). Similar percentage
of overlap was obtained for other filtering conditions.
Because FTO is an m6A eraser, we next compared FTO
binding with positions of known m6Amodifications. Meta-
gene analysis revealed a peak of FTO binding around
known m6A sites (17) (Figure 1B). Moreover, we observed
a 16% overlap between exons modified by m6A and exons
bound by FTO (Supplementary Figure S2A, B).
Previous studies revealed m6A enrichment around tran-
scription start sites (TSS) and stop codons (1,2). To exam-
inewhether FTOmight be involved in the regulation ofm6A
abundance around these features, we compared the distribu-
tion of FTOCLIP reads inmRNA transcripts with the pub-
lished m6A-seq results (1). Our CLIP-seq analysis revealed
pronounced enrichment of FTO binding at TSS (Figure
1C) and a moderate enrichment around stop codons (Sup-
plementary Figure S2C). Interestingly, we detected a peak
of FTO enrichment at around 100nt upstream of known
poly(A) sites (Figure 1D), which was different from the dis-
tribution of m6A reads. M6A was more dispersed through-
out a wide region upstream of poly(A) sites (Figure 1D) in-
dicating that it is enriched more generally throughout the 3′
UTRs and that FTO may be removing a specific subset of
the marks close to 3′ends of mRNAs.
In order to look whether FTO might have a target
sequence preference, we performed motif search analy-
sis in the CLIP-seq datasets. Although, we did not ob-
serve enrichment around the DRACH motif (Supplemen-
tary Figure S2D and E), the FTO reads were enriched in
several pyrimidine-rich sequences (Supplementary Figure
S2E). Moreover, these motifs were reproducibly occurring
in all three replicates of CLIP (Supplementary Figure S2E).
However, the most enriched motif occurs only in ∼5% of
FTObound sequences (Supplementary Figure S2E). There-
fore, although the newly found motifs are strongly associ-
ated with FTO binding, they do not appear essential for
RNA recognition by FTO.
To validate the FTO CLIP-seq results, we performed
anti-FLAG-based RNA immunoprecipitation (IP) coupled
to RT-PCR (RIP-PCR) with gene-specific primers. The IP
samples from FLAG-FTO cells revealed a strong signal for
all RNAs examined, four mRNAs and three ncRNAs (Fig-
ure 1E). On contrary, FLAG-GFP IP, which was used as
a background control, showed very weak or no coprecipi-
tation of the tested RNAs (Figure 1E). Taken together, we
provide a transcriptome-wide map of RNAs bound by the
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Figure 1. Identification of FTO targets by CLIP-seq analysis. (A) The distribution of CLIP-seq reads among individual RNA classes. Reads were cat-
egorized according to the priority table (See methods) (B–D) Metagene distribution of FTO CLIP and m6A-seq reads around positions of m6A (B),
transcription start site (TSS) (C) and poly(A) sites (D). (E) RNA IP confirmation of FTO binding to RNAs identified by CLIP-seq (upper panel). Repre-
sentative exonic and ncRNAbinding sites were selected and gene names are indicated on the left.Western blot analysis of FLAG-FTO immunoprecipitation
(IP) efficiency (lower panel). FLAG-GFP was used as a background control. Inp is the whole cell lysate. El is the bound fraction. FT (Flow-through) is
the unbound fraction.
m6A demethylase FTO, which revealed a significant over-
lap with the previously identifiedm6A locations withinmR-
NAs.
FTO targets pre-mRNAs in the nucleus
To address the function of FTO binding in 293T cells, we
performed immunofluorescence localization of endogenous
FTO in the control 293T cells and of the 3xFLAG-FTO
stably integrated in the 293T cell line. In both cases, FTO
localized predominantly to the nucleoplasm (Figure 2A).
Consistently with nuclear localization, the majority of FTO
CLIP-seq reads that correspond to protein-coding genes
fall into intronic regions (74% of all mRNA reads, Figure
2B). The remaining 26% of mRNA reads fall into 3′ UTRs
(10.3%), coding regions (12.2%), and 5′ UTRs (3.4%) (Fig-
ure 2B). Moreover, the intronic binding of FTO was highly
reproducible between the three replicates (Figure 2D, Sup-
plementary Figure S1C and D).
To further examine the FTO binding to pre-mRNAs, we
analyzed and compared the number of reads spanning the
intron-exon boundaries and exon-exon junction regions, re-
spectively. Our results revealed a significantly higher ratio
of exon-intron spanning reads relative to exon-exon junc-
tion reads in FTO CLIP-seq compare to the total RNA
input (RNA-seq) (P = 7.3 × 10−5, Student’s t-test, Figure
2C). FTObinding to intron-containing pre-mRNAwas fur-
ther experimentally validated by FTO RIP-PCR. We used
primers annealing and amplifying intronic regions signif-
icantly enriched in the FTO CLIP-Seq data (Figure 2D).
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The result in Figure 2E demonstrates that FTO coprecip-
itated three different intron-containing mRNAs, whereas
weak or no signal was observed in samples where FLAG-
GFP expressing cells were used as a background control.
In summary, our experiments and analyses strongly imply,
that FTO targets intronic regions in pre-mRNAs.
Depletion of FTO leads to gene expression changes
Next, we asked whether mRNA binding by FTO or its
demethylation activity could affect gene expression.We tar-
geted exon 2 of FTO using a CRISPR-Cas9 system and gen-
erated a 293T FTO−/- cell line (FTOKO) with abolished ex-
pression of both alleles of the FTO gene (Figure 3A). FTO
KOcells displayed slower growth rate compared to the 293T
control cell line (Supplementary Figure S3A). To investi-
gate changes in gene expression, we performed 2 × 125 bp
paired-end whole transcriptome sequencing (RNA-seq) of
cDNA libraries prepared from rRNA-depleted total RNA
with high sequencing depth. Gene expression was estimated
using the R package DESeq2 (48). We observed differen-
tial expression (DE) of more than 0.5log2 fold in 846 pro-
tein coding genes (FDR < 0.05), of which 677 were down-
regulated in FTO KO cells, and 169 were upregulated (Fig-
ure 3B). We were able to validate the expression changes in
either direction in five out of six selected mRNAs by RT-
qPCR (Figure 3C). The DE data are consistent with the
expected hypermethylation of mRNA in FTO KO and the
known role of m6A in reduction of RNA stability (4).
We also investigated whether FTO-bound genes display
a specific change of expression upon FTO deletion. To ad-
dress this question, we compared the differential expression
profile of genes bound by FTO with the differential expres-
sion profile of all genes (Figure 3D, Supplementary Figure
S3B). Surprisingly, we did not detect a pronounced differ-
ence between the gene expression profiles. Thus, we con-
cluded that regulation of gene expression and mRNA sta-
bility might not be the major role of nuclear FTO. We next
focused on the possible role of FTO in mRNA processing.
FTO triggers inclusion of alternatively spliced exons
FTOwas previously linked to regulation of alternative splic-
ing of a single gene RUNX1T1, which has an important
role in adipogenesis (19,21). Furthermore, our CLIP-seq
and RNA-seq data point towards a function of FTO in
nuclear mRNA processing. To examine the role of FTO
in alternative splicing globally we carried out exon expres-
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sion analysis of FTOKORNA-seq data with DEXSeq (49)
and AS analysis withMISO (50). Both approaches revealed
multiple differential splicing events relative to the control
cell line (Table 1). Interestingly, these were predominantly
exon-skipping events in FTO KO cells (957/1362 DEXSeq,
156/204 MISO; Table 1). We observed around 20% overlap
of genes with significantly changed exon expression found
by DEXSeq and significant difference of PSI estimated by
MISO. A detailed view of a selected alternative splicing
event (BRD8 gene) showing RNAseq read coverage across
splice junction is represented in Figure 4A. Based on these
analyses we selected six alternative splicing events and we
were able to validate five of them using semi-quantitative
PCR with primers annealing to flanking exons (Figure 4B).
To further examine whether the demethylation activity of
FTO, and thus the m6A, are involved in the regulation of
theAS events, we stably reintroducedWTFTOand catalyti-
cally inactive mutant FTO (in -ketoglutarate coordinating
site H231A, D233A), respectively into the 293T FTO KO
cell line. Whereas the WT FTO expression partially rescued
the exon skipping phenotype of the FTO KO (Figure 4B),
the splicing pattern in mutant FTO cells was comparable to
FTO KO (Figure 4B).
To further validate the alternative splicing phenotype, we
prepared a reporter minigene construct, in which the alter-
native exon of BRD8 together with surrounding intronic re-
gions was inserted between heterologous exons of the rat in-
sulin gene (Figure 4C). The experiments with the reporter
construct revealed 68%versus 54% exon inclusion in control
293T versus FTOKO cells, respectively, which is highly sim-
ilar to the splicing patterns observed in endogenous BRD8
(75% control and 57% in FTO KO, respectively).
To address whether FTO binding correlates with exon in-
clusion, we compared FTO CLIP-seq coverage around top
200 most significantly excluded alternative exons to the to-
tal set of 339881 cassette exons present in MISO splicing
events database. Because MISO does not support replicates
we pooled the three replicate libraries together and also per-
formed the analyses separately for each replicate. Alterna-
tive splicing events were scored and selected from the pooled
analysis. Individual AS events selected for validation were
then examined in each replicate separately and reproducibil-
ity was tested by the t-test.We found the highest enrichment
of FTO binding in both exons and introns adjacent to the
excluded exons (Figure 4D, E). There was also a slight en-
richment of FTO binding in the entire transcripts that con-
tained excluded exons (Figure 4F). Conversely, we found
that FTO binding was not significantly increased around
exons that were more included in FTOKO (Supplementary
Figure S4B). The CLIPseq results showed a strong enrich-
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Table 1. Summary of differential expression and splicing events found by MISO and DEXSeq. KO of FTO leads predominantly to skipping of internal
cassette exons and upregulation of last exons
Downregulated (skipping) Upregulated (inclusion)
FTO Internal exons 957 405
MISO AS events 156 48
Last exons 32 869
METTL3 Internal exons 1525 1061
Last exons 498 48
ment of binding in the flanking introns of the BRD8 AS
exon 20/21. Therefore, we used the reporter construct (Fig-
ure 4C) to try to narrow down the FTO target sequence. We
selected a 53 nt long region in the downstream intron, that
showed the highest FTO coverage and prepared mutant re-
porters lacking the whole region or replaced by a heterolo-
gous sequence (Supplementary Figure S4A). Interestingly,
this 53 nt region contains two putativeDRACHmotifs. The
mutant reporters showed higher exon inclusion than the wt
form in FTO KO cells (Supplementary Figure S4A). A mi-
nor increase in exon inclusion from mutant constructs was
also observed in control 293T cells, which is consistent with
the model that absence of m6A marks inhibits exon inclu-
sion in this AS event (Supplementary Figure S4A). In sum-
mary the minigene experiments supports our finding that
the selected region is involved in AS of BRD8 exon 20/21.
To test whether the FTO-related alternative splicing
events also correlate with m6A modification, we compared
the m6A abundance around alternatively spliced exons. The
m6A marks were strongly enriched at intronic as well as ex-
onic regions surrounding skipped exons in FTO KO cell
line, but not in the whole mRNAbody (Supplementary Fig-
ure S4C). Interestingly, m6A was also not enriched around
exons that were differentially included uponFTOdepletion.
Finally, transcripts with more included exons in FTO−/−
cells displayed overall higher level of m6A marks (Supple-
mentary Figure S4C). In conclusion, the preferential bind-
ing around skipped exons and prevalence of exon skipping
events in FTO KO, suggested that the demethylation of
mRNA transcripts by FTO directly promotes exon inclu-
sion under normal conditions.
Previous studies showed that transcripts of housekeep-
ing genes are devoid of m6A marks (5). To address whether
proteins encoded by the FTO-regulated alternative mRNA
isoforms belong to specific cellular pathways, we performed
a GO term enrichment analysis of the alternatively spliced
transcripts. We used mRNAs that shared both features: re-
vealed exon skipping in FTO KO cells and were identified
by FTO CLIP-Seq analysis. The analysis showed a signifi-
cant overrepresentation of genes encoding factors involved
in cell cycle, nucleic acids binding and metabolism and gen-
eral metabolic processes (Supplementary Figure S4D).
FTO regulates expression of last exons
On top of the changes in AS, the DEXSeq analysis revealed
that last exons underwent differential expression more fre-
quently than expected by chance (Table 1; P = 1.62 ×
10−233, Fisher’s exact test). Differentially expressed last ex-
ons were almost exclusively upregulated (860 upregulated
vs 32 downregulated; FDR< 0.05; Table 1, Figure 5A, B, P
< 2.2× 10−16 Mann-Whitney U-test), suggesting that FTO
might play a role in regulation of expression and/or pro-
cessing of mRNAs 3′ ends. To gain further insights into the
profile of expression change at the 3′ mRNA termini, we
performed a metagene analysis of 3818 transcript isoforms,
which overlap with 892 DE 3′ terminal exons in FTO KO.
We observed a strong increase in RNA-seq coverage in re-
gions ranging from stop codons and covering the whole 3′
UTR inFTOKOcompared to control cells (Supplementary
Figure S5A).
Next we investigated the relation between FTO binding
and DE of last exons. To examine the precise location of
FTO binding in last exons, we performed metagene anal-
ysis of 1258 and 1298 RefSeq transcripts overlapping with
downregulated and upregulated last exons, respectively. We
found that FTO CLIP-seq signal shows a peak of enrich-
ment close to the poly(A) sites for transcripts with upreg-
ulated last exons, compared to transcripts with downregu-
lated last exons (Figure 5C). As expected, no difference in
enrichment of FTO binding was observed around putative
poly(A) sites of transcripts with DE internal exons (Sup-
plementary Figure S5B). These findings suggested thatm6A
and FTOmight be involved in the regulation of poly(A) site
selection and potentially in the control of 3′ UTR length.
This is in agreement with the recent study that revealedm6A
enrichment in last exons and its proposed role in the regu-
lation of 3′UTRs (32).
To examine the significance of the last exon expression
in FTO KO cells, we investigated whether the change in
RNAseq coverage in FTOKOmight be associated with the
usage of alternative polyA sites (APA) using daPars (55)
(Figure 5A). Consistently with DEXseq analysis, FTO KO
cells showed pronounced higher usage of distal APAs com-
paring to the control cells (Figure 5D). To further support
the involvement of APA in FTO KO cells, we plotted the
ratio of FTO KO/WTRNAseq coverage around the anno-
tated proximal polyA sites (58). We found that the change
in coverage was strongly associated with the most proximal
polyA site in the last exon (Supplementary Figure S6A),
but not with the most proximal polyA site upstream of the
last exon (Supplementary Figure S6B). This indicated, that
FTO promotes usage of proximal APAs in a subset of genes.
Therefore we tried to look whether these positions are bona
fide cleavage sites. For that, we used the PAR-CLIP results
of several 3′ end processing factors, that were obtained from
T293 cells (59) and plotted their binding around APA sites
predicted by daPars (767 sites). We observed a discrete peak
of binding of the Cleavage and Stimulatory Factor CSTF64
and Cleavage Factor I 68 at FTO-linked APAs (Supplemen-
tary Figure S7A). Altogether, these data support the direct
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role of FTO in selection of APA sites in human cell culture
model.
FTO and METTL3 act reciprocally in the regulation of al-
ternative splicing and 3′ UTR expression
To investigate the relevance of m6A in FTO-dependent ter-
minal exon upregulation, we examined the transcriptome
analysis of cells with downregulated METTL3 (METTL3
KD) published by Liu et. al. (7). METTL3 KD data dis-
played a significant downregulation of 3′ terminal exons
(P = 9.38 × 10−154, Mann-Whitney U-test, Figure 6A, C),
which is the opposite effect to the last exon upregulation
in the FTO KO (Figure 6B). Overall, 88% of last exons
(498/546) that were DE with at least 0.5log2 fold change
were downregulated (Table 1). On the other hand, the ef-
fect on internal exons was not strictly unidirectional in
METTL3 KD (Figure 6C). Most importantly, we observed
an inverse correlation between the exon expression in FTO
KO and METTL3 KD cells for both internal and terminal
exons, supporting the functional involvement of the m6A
pathway (Figure 6D, R = 0.57, Pearson correlation). Fi-
nally, we aimed to examine the global expression of genes
with DE terminal exons in the FTO KO cell line. We se-
lected 938 genes showing significant (FDR < 0.05) DE of
their 3′ exons and plotted their change of gene expression in
comparison to the change of expression of all genes in the
FTOKOcell line.We found a significant upregulation of ex-
pression of genes with upregulated 3′ ends (Mann-Whitney
U-test P = 1.13 × 10−18, Figure 6E). In conclusion, these
data revealed an opposite effect of METTL3 and FTO in
regulation of expression of internal and 3′ terminal exons,
which strongly supports the role of m6A methylation path-
way in the regulation of 3′ mRNA processing and alterna-
tive splicing.
DISCUSSION
The enrichment of m6A marks can have significant conse-
quences onmultiple aspects of mRNAmetabolism. Despite
the increasing number of m6A studies, it is still unclear why
adenosines are preferentially modified at specific locations
within transcripts, or what are the functional consequences
of such patterns of methylation. It is tempting to speculate
that demethylases are important players that decide about
the final m6A pattern. Here, we report a transcriptome-
wide mapping of the FTO m6A demethylase binding sites
on RNAs and reveal the connection between FTO binding,
activity and pre-mRNA processing.
In our model system, FTO is primarily localized to
the nucleoplasm, where it appears to modulate several
pre-mRNA processing events. FTO binding sites partially
overlap with m6A-associated features, such as TSS and
stop codons (1,2), which experimentally demonstrates the
predicted effect of demethylation on m6A abundance at
these sites. In mRNAs, m6A is frequently enriched in the
DRACH consensus motif. Surprisingly, our CLIP-seq ex-
periment revealed no significant enrichment of DRACH
among FTO targets. We hypothesize that FTO may re-
move adenosine methylation marks also on non-DRACH
sequences, and thus contributes to the pattern of m6A dis-
tribution. A recent study indicated that FTO andALKBH5
discriminate their m6A targets based on structural rather
than primary sequence properties in vitro (38). However,
we have not observed higher folding energies in FTO-
bound regions. Moreover, in the course of the revision of
this manuscript, the work of Mauer et al. (60) uncovered,
that FTO preferentially demethylates non-DRACH N6,2′-
O-dimethyladenosine (m6Am) present downstream of the
mRNA 5′ cap. This well correlates with the FTO binding
enrichment around TSS observed in our datasets (Figure
1C).
Adenosine methylation is a dynamic process that among
others contributes to the flexible regulation of gene ex-
pression at the level of mRNA stability (3,4,8). The m6A
marks in the 3′ UTRs promote mRNA destabilization via
the recruitment of the cytoplasmic YTHDF2 m6A reader
(4). However, our data suggest that the main role of nu-
clear FTO is regulation of pre-mRNA processing rather
than regulation of mRNA expression. This hypothesis is
supported by the large proportion of intronic and exon-
intron boundary reads in the FTO CLIP-seq as well as
the absence of correlation of FTO binding and gene ex-
pression. Additionally, studies investigating the mRNA in-
teractome identified components of the methylase com-
plex (METTL3, KIAA1429) and all known YTH proteins
(YTHDF1, YTHDF2, YTHDF3, YTHDC1, YTHDC2)
as poly(A)-RNA interacting proteins (61,62). FTO was not
detected in the poly(A) RNA interactome suggesting that it
does not interact with mature mRNA. Taken together, we
propose pre-mRNA as the major substrate of FTO.
Recent work of Ke et al. suggested that higher m6A den-
sity in last exons could influence the usage of alternative
poly(A) sites (APA) (32). Notably, our CLIP-seq analysis
revealed a substantial enrichment of FTO binding in up-
regulated last exons, which was particularly pronounced in
the close proximity to poly(A) sites. Moreover, we demon-
strated, that FTO acts at APAs that are actively used and
regulated in the 293T cells. In this context, the upregulation
of last exons in FTO KO cells points to the role of methyla-
tion dynamics in regulation of APA usage and in turn con-
trol of 3′ UTR length.
Several lines of evidence established them6A as an impor-
tant pre-mRNA splicing regulator. WTAP was originally
known as a splicing factor in Drosophila (63) and downreg-
ulation of several players in the m6A pathway was previ-
ously shown to affect the AS pattern of thousands of genes
(18,20,21). The data presented in this work further demon-
strated that FTO binds pre-mRNAs in vivo, allowing for
AS regulation and that FTO depletion causes mainly exon
skipping phenotypes. These conclusions are supported by
data from FTO CLIP-seq, RNA-seq of WT and FTO KO
cell lines and by subsequent RT-PCR validation on several
endogenous transcripts, as well as a reporter construct. To
narrow down the FTO-regulated RNA element, we intro-
duced mutations in the FTO binding region, which par-
tially reverted the alternative splicing phenotype of FTO
KO. However, since FTO CLIP-seq data showed additional
peaks across the AS exon and flanking introns, we conclude
that the effects of elements responsible for the AS regula-
tion are additive and cannot be fully abolished by mutating
only a single site.
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Figure 6. FTO andMETTL3 deficient cell lines show anti-correlated 3′ UTR expression phenotype. (A) Cumulative distribution of expression of all exonic
parts and exonic parts originating from last exons in METTL3 KD as calculated by DEXseq. P value is estimated by the Mann-Whitney U-test. (B, C)
Boxplot showing differential expression of exonic parts in FTOKO (B) andMETTL3 KD (C) based on the exon number from the 3′ end. Significance was
calculated by a two-tailed t test. ***P < 1 × 10−20. (D) Scatterplot of expression change of exons that were called differentially expressed by DEXSeq in
both FTO KO and METTL3 KD. R represents the Pearson correlation coefficient. (E) Cumulative distribution of differential expression of genes which
have significantly changed expression of their 3′ terminal exonic part. P value is estimated by the Mann-Whitney U-test. (F). Schematic summary of the
reported roles of FTO-dependent m6A and m6Am modifications. Reversible m6Am modification of the nucleotide adjacent to the 7-methylguanosine cap
affects mRNA stability (60) and reversible m6A modification on the 5′UTR promotes cap-independent translation initiation under stress conditions (23–
25). At the pre-mRNA body, FTO regulated m6Amodification promotes exon inclusion/skipping, likely depending on the cellular context and interacting
splicing factors (19,21). At the 3′UTR, FTO dependent m6A modification potentially regulates APA usage and the length of 3′UTR.
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FTObinding primarily to pre-mRNA intronic regions re-
sembles the CLIP-seq results of METTL3-METTL14 pub-
lished by other groups in which they reveal mainly intronic
occupancy (29–34%) (7). Given its nucleoplasmic localiza-
tion, FTO appears to also act on pre-mRNAs in concert
with the methylase complex. These data support the hy-
pothesis that a large number of intronic adenosines are
methylated co-transcriptionally, enabling potential regula-
tion of nuclear events. This would allow the regulation of
alternative splicing events observed in our RNA-seq analy-
sis of FTO KO cells. Because FTO depletion leads mostly
to exon skipping AS events and FTO binding is enriched
around skipped exons, demethylation appears to be im-
portant to facilitate exon inclusion in a subset of AS re-
gions. Interestingly, several recent studies proposed novel
m6A-dependent molecular mechanisms regulating alterna-
tive splicing. The direct recognition of m6A-enriched AS
exons by the reader YTHDC1 facilitates their inclusion
into mRNA. YTHDC1 recruits the SRSF3 splicing fac-
tor, which promotes exon inclusion and simultaneously pre-
vents binding of SRSF10, which drives exon exclusion. As
a consequence, 160 long AS exons are included into mature
mRNA (18). A similar subset of AS exons is then excluded
in the absence ofm6A.Anotherm6Amechanism to regulate
AS is based on RNA conformational changes induced by
the modification. The m6A-mediated structural switch en-
hances binding of the splicing factor hnRNPC (20), which
in turn affects splicing of adjacent exons (20). A parallel
study showed that accumulation of m6A marks upon FTO
depletion in mouse pre-adipocytes promotes binding of an-
other splicing factor, SRSF2, which leads to increased in-
clusion of target exons (21). The fact that we observe an
opposite trend upon FTO depletion in 293T cells suggests
that FTO-mediated m6A enrichment leads to altered bind-
ing of different splicing factors depending on the cellular
and mRNA context. This would resemble the opposing
roles on SRSF3 and SRSF10 factors. Notably, studies in
the Drosophila system by (64–66) show that m6A deficient
Ime4/Yt521-B mutant flies exhibit aberrant exon inclu-
sion in Sxl exon3. This is consistent with exon skipping phe-
notype observed in FTO KO human cell lines and associ-
ation of FTO activity (which reduces m6A content) with
exon inclusion.
Recent work from Ke et al. (67) uncovered that m6A
deposition occurs mostly on chromatin-associated pre-
mRNAs prior to the completion of pre-mRNA processing
and the overall m6A deposition does not change after the
mRNA is released from chromatin. They observed the high-
est density of m6A in exonic regions even though introns
represent majority of pre-mRNAs and contain higher pro-
portion of DRACHmotifs. This is consistent with our find-
ings, that FTO binds to pre-mRNAs and mediates m6A re-
moval in introns. The major conclusion of Ke et al. study
points to the role of m6A mostly in regulation of mRNA
stability (67). Nevertheless, the transcriptome-wide analy-
ses of splicing patterns in wild type andMETTL3KOESCs
and also reanalyzed datasets from (2) (20,21) showed that
perturbation of m6A causes a minor, but genuine effect on
splicing of alternative exons with m6A modifications (67).
This is in agreement with our conclusions on the role of
FTO in regulating alternative splicing of a subset of exons
in HEK293T cells.
The inconsistency between published reports illustrates,
that the mechanism of m6A in regulation of constitutive
and alternative splicing is not well established, yet. Cer-
tain discrepancy in this context might be caused by selec-
tive analyses of isolated effects of m6A on splicing in the
context of other splicing factors. Although, in specific cases,
m6A promotes exon inclusion (18) or exon exclusion (64–
66), drawing conclusions about general effect of m6A onAS
might not be relevant. It rather seems that the effect of m6A
addition/removal is transcript-specific and depends on par-
ticular downstream effectors.
Finally, the removal of m6A by FTO is a multi-step
process. It can generate up to two intermediates (N6-
hydroxymethyladenosine (hm6A) and N6-formyladenosine
(f6A)) with expected lifetimes of around 3 hours (68). It
means that these intermediates could also be recognized by
different factors and change the fate of the modified tran-
scripts. Moreover, in each of the above-mentioned stud-
ies, only a small subset of exons reacted to the particular
splicing factors. It is likely that m6A affects multiple inde-
pendently acting factors and thus can have adverse conse-
quences. This is supported by finding of Xiao et al. who
showed that YTHDC1 does not directly interact with an-
other m6A-responsive splicing factor, such as hnRNPC or
ELAVL1 (18). The identification of m6Am as a new target
of FTO adds to the complexity of the picture (60). Unfor-
tunately, we do not know which additional splicing factor
responds to m6A or m6Am enrichment upon FTO deple-
tion.However, our data for the first time demonstrate the di-
rect link between FTO activity, mRNAbinding andmRNA
processing consequences.
The m6A and m6Am decoration of RNA is a dynamic
process with a wide spectrum of consequences, which have
been connected to many important mRNA metabolic pro-
cesses. However, themRNAdemethylation still remains one
of the most elusive steps in the RNA methylation pathway.
In this study, we demonstrated that RNA demethylase FTO
acts primarily in the nucleus, where its demethylation ac-
tivity regulates pre-mRNA processing including alternative
splicing and 3′ UTR processing (Figure 6F). These results
add an additional component to the mosaic of adenosine
methylation-regulated processes in mammalian cells.
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